The latest myeloma news, all in one place. Find research updates, expert interviews, and more on SOHO Insider, including coverage from SOHO 2026. Go to sohoinsider.com/category/mul...
@societyofhemonc.bsky.social
@societyofhemonc.bsky.socialThe latest myeloma news, all in one place. Find research updates, expert interviews, and more on SOHO Insider, including coverage from SOHO 2026. Go to sohoinsider.com/category/mul...
@cancergrace.bsky.socialDr. Blue is explaining more at Blood Cancers OncTalk 2026. Join us now to hear more about it!
👉 Join for free: give.cancergrace.org/event/blood-...
@cancergrace.bsky.socialJoin us now to hear more about it! It’s free:
give.cancergrace.org/event/blood-...
@cancergrace.bsky.social
@naturesfairy.bsky.socialI’m at the Cancer Center getting my first round of Iron Infusion. Praying I don’t have any adverse reactions. Hard for me to sit still for 3 hours. So far so good.
#yougotthis
#youarestrong
#multiplemyeloma
#staypositve
@cancergrace.bsky.socialRegister for free at cancergrace.org
📅 October 10, 2026
⏰ 11:00 a.m. ET
💻 Virtual and free event
#BloodCancers #Leukemia #Lymphoma #BloodCancer #MultipleMyeloma
@seasherm.bsky.socialGood news for me this week. I've been in weekly chemo for Multiple Myeloma for the last 8 months. This week they told me that I'm switching to a maintenance program once a month with fewer drugs. My blood test numbers have really improved. #Myeloma #MultipleMyeloma it's nice to be alive.
@scienceinboston.comA phase 1 clinical trial led by Dr. Matthew Frigault at @mgbresearch.bsky.social has found that an investigational #CART therapy can lead to deep and durable responses in people with relapsed/refractory #MultipleMyeloma.
Press release: https://bit.ly/4z2tnFL
Abstract: https://bit.ly/3VjTmtU
@cancertherapyadv.bsky.socialCurious about highlights from #IMS26?
We spoke with our advisory board member, Rahul Banerjee, MD, about his takeaways from this year's meeting including the MajesTEC-3 & CERVINO clinical trials! #MultipleMyeloma
Check them out here: https://bit.ly/3TfcB7m
@vcclibrary.bsky.socialIberdomide plus daratumumab and dexamethasone versus daratumumab, bortezomib, and dexamethasone in patients with relapsed or refractory #MultipleMyeloma (EXCALIBER-RRMM): an open-label, randomised, controlled, phase 3 trial. www.thelancet.com/journals/lan...
@vcclibrary.bsky.socialNICE Technology Appraisal Guidline [TA1195]: Daratumumab with bortezomib, lenalidomide and dexamethasone for untreated #MultipleMyeloma when a stem cell transplant is suitable. www.nice.org.uk/guidance/ta1...
@thecancersurvivorsclub.comLess treatment could still bring meaningful relief. Ultra-low-dose radiation given in just one or two sessions controlled painful bone lesions without further radiation in 81% of evaluable multiple myeloma patients in a trial.
@hemehub.bsky.social🩸The HemeHub Hematology Summit is just 2 days away!
Here’s a preview of the schedule, bringing together expert insights and panel discussions for a full day of learning!
Full program and event details: hemehub.org/events/hemeh...
#HemeHub #HemeOnc #Myelofibrosis #MultipleMyeloma #CLL #PNH #DLBCL
@hemehub.bsky.social🩸Our case discussion on Smoldering Multiple Myeloma with Shaji Kumar, MD and Adeel Khan, MD is now available to watch on YouTube!
⮕ Watch the full session: youtu.be/vbFJmFe0vjE?...
#SmolderingMyeloma #MultipleMyeloma #Myeloma #Hematology #HemOnc #Oncology #MedicalEducation #MedEd #HemeHub
@ancan501c3.bsky.socialBLOOD CANCERS: If you need some encouragement and #peersupport, look no further. Drop into our #BloodCancer support group TONIGHT 8pm ET / 5pm PT
➡️https://www.gotomeet.me/ancanschmier
#CLL #leukemia #lymphoma #multiplemyeloma #nonhodgkinslymphoma
@bmtinfonet.bsky.socialWhat if myeloma returns after CAR T-cell therapy? Muthalagu Ramanathan, MD, addresses that question, along with who may be considered for CAR T and what treatment involves. Watch or read:
@hematologyadvisor.bsky.socialFixed-duration linvoseltamab therapy yielded a 100% ORR & prevented progression to active disease, with a manageable safety profile, in patients with high-risk smoldering #MultipleMyeloma!
From the updated phase 2 LINKER-SMM1 study presented at #IMS26
🔗 Read more: https://bit.ly/4hnw8M7
@healthcaretoday.bsky.socialResearchers at The Royal Marsden NHS Foundation Trust have found that routine whole-body MRI scans can reveal far more about multiple myeloma patient health than simply showing where their cancer is.
@hemehub.bsky.social🩸 We extend our gratitude to our Silver-Level Sponsor, Bristol Myers Squibb (@bmsnews.bsky.social ), for supporting the HemeHub Hematology Summit on October 3!
🌐 Explore more: hemehub.org/events/hemeh...
#HemeHub #HemeOnc #HematologySummit #Myelofibrosis #MultipleMyeloma #CLL #PNH
@breakingnews06.bsky.socialLady A’s Charles Kelley Shares Rare Blood Cancer Diagnosis #CharlesKelley #LadyA #MultipleMyeloma #BloodCancerAwareness #SupportCharlesKelley